A much-awaited stage of the vaccination campaign was announced, as the Minister of Health and Social Services, Christian Dubé, confirmed that appointments for the general population will begin shortly.
As of April 30th, depending the goal is to open vaccination to everyone within two weeks.
Take a look at the
featured Local Savings
at the bottom of this page!
| Opening of making appointments | Age group | Target population vaccinated (75%) | First dose | Scheduled meetings for 1 dose | Appointment to take to reach the target |
| 30 April | 50 to 59 | 866 387 | 475 737 | 129 643 | 261 007 |
| May 3 | 45 to 49 | 396 921 | 158 258 | 61 887 | 176 776 |
| May 5 | 40 to 44 | 439 574 | 99 556 | 48 150 | 291 868 |
| May 7 | 35 to 39 | 423 543 | 87 039 | 39 974 | 296 530 |
| May 10 | 30 to 34 | 415 429 | 74 090 | 34 891 | 306 448 |
| May 12 | 25 to 29 | 413 982 | 69 939 | 29 316 | 314 727 |
| May 14 | 18 to 24 | 498 348 | 67 588 | 28 923 | 401 837 |
Large confirmed deliveries of vaccine doses are expected during the next few weeks and vaccinations for the general population will begin shortly. The total number of planned doses is 2,517,080, broken down as follows:
- 594,770 doses during the week of May 3;
- 458,640 doses during the week of May 10;
- 458,640 doses during the week of May 17;
- 458,640 doses during the week of May 24;
- 546,390 doses during the week of May 31.
“After opening vaccination to all priority groups, we are finally able to start making appointments for the rest of the adult population. This is great news. I am very proud of what we have accomplished so far, and also of the public’s response. Vaccination is the best solution that will allow us to return to normal life. Several weeks will still be needed to protect a sufficiently large part of the population, but we are approaching the goal. » said Christian Dubé, Minister of Health and Social Services
- Over the past few days, appointment scheduling has been extended to people with a disability, as well as one caregiver per person in this clientele, and pregnant women.
- Following the confirmation, on April 27, of the death of a person following a thrombosis with thrombocytopenia (VIPIT) which occurred after the administration of a viral vector vaccine against COVID-19, namely the vaccine AstraZeneca (Covishield), the public is advised to take into consideration that these cases remain very rare. The benefits of the vaccine are considered to far outweigh the risks. However, it is important to remember that people who have received this vaccine should consult a doctor or Info-Santé promptly if, particularly within 4 to 20 days following vaccination, the following symptoms appear:
- shortness of breath, pain in the chest, leg swelling, or stomach pain;
- a severe headache or a headache that has lasted for a few days, blurred vision or bruising on the skin.
